Khandani AH - Search Results

1

Khandani AH, Wahl RL. Khandani AH, et al. Radiol Clin North Am. 2005 Sep;43(5):849-60, vii. doi: 10.1016/j.rcl.2005.05.008. Radiol Clin North Am. 2005. PMID: 16098343 Review.

2

Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer.

Detterbeck FC, Vansteenkiste JF, Morris DE, Dooms CA, Khandani AH, Socinski MA. Detterbeck FC, et al. Among authors: khandani ah. Chest. 2004 Nov;126(5):1656-66. doi: 10.1378/chest.126.5.1656. Chest. 2004. PMID: 15539740 Review.

3

Intra-individual variability of cardiac uptake on serial whole-body 18F-FDG PET.

Khandani AH, Isasi CR, Donald Blaufox M. Khandani AH, et al. Nucl Med Commun. 2005 Sep;26(9):787-91. doi: 10.1097/01.mnm.0000175264.33368.da. Nucl Med Commun. 2005. PMID: 16096582

4

Can the relation between gadopentetate dimeglumine and FDG uptake in colorectal liver metastases be used clinically?

Khandani AH, Semelka RC. Khandani AH, et al. Radiology. 2005 Oct;237(1):1-2. doi: 10.1148/radiol.2371050766. Radiology. 2005. PMID: 16183917 No abstract available.

5

Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancer.

Khandani AH, Whitney KD, Keller SM, Isasi CR, Donald Blaufox M. Khandani AH, et al. Nucl Med Commun. 2007 Mar;28(3):173-7. doi: 10.1097/MNM.0b013e328013ebc5. Nucl Med Commun. 2007. PMID: 17264775

6

A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.

Khandani AH, Calvo BF, O'Neil BH, Jorgenson J, Mauro MA. Khandani AH, et al. AJR Am J Roentgenol. 2007 Nov;189(5):1199-202. doi: 10.2214/AJR.07.2126. AJR Am J Roentgenol. 2007. PMID: 17954661 Clinical Trial.

7

Simultaneous FDG PET+/Glut1+ lung and FDG PET-/Glut1- subcarinal lymph node metastases from prostate cancer.

Khandani AH, Funkhouser WK, Feins R, Socinski MA. Khandani AH, et al. Ann Nucl Med. 2009 Aug;23(6):595-7. doi: 10.1007/s12149-009-0264-2. Epub 2009 May 13. Ann Nucl Med. 2009. PMID: 19437096

8

Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomography.

Khandani AH, Dunphy CH, Meteesatien P, Dufault DL, Ivanovic M, Shea TC. Khandani AH, et al. Nucl Med Commun. 2009 Aug;30(8):594-601. doi: 10.1097/MNM.0b013e32832cc295. Nucl Med Commun. 2009. PMID: 19536037

9

Non-small cell lung cancer: prognostic importance of positive FDG PET findings in the mediastinum for patients with N0-N1 disease at pathologic analysis.

Xie L, Saynak M, Veeramachaneni NK, Fried DV, Jagtap MR, Chiu WK, Higginson DS, Lawrence MV, Khandani AH, Qaqish BF, Chen RC, Marks LB. Xie L, et al. Among authors: khandani ah. Radiology. 2011 Oct;261(1):226-34. doi: 10.1148/radiol.11110199. Epub 2011 Aug 3. Radiology. 2011. PMID: 21813742

10

Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT?

Mirpour S, Meteesatien P, Khandani AH. Mirpour S, et al. Among authors: khandani ah. Rev Esp Med Nucl Imagen Mol. 2012 Mar-Apr;31(2):71-7. doi: 10.1016/j.remn.2011.05.006. Epub 2011 Nov 16. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 22088805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page